Transcriptional suppression by transient recruitment of ARIP4 to sumoylated nuclear receptor Ad4BP/SF-1

Molecular Biology of the Cell

Volumn 20, Issue 19, 2009, Pages 4235-4245

  Ogawa, Hidesato ^a,b,c   Komatsu, Tomoko ^a,d   Hiraoka, Yasushi ^b,c   Morohashi, Ken Ichirou ^a,e  

^a NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

^b NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTES OF NATURAL SCIENCES   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANDROGEN RECEPTOR; AR INTERACTING PROTEIN 4; DOUBLE STRANDED DNA; LIVER RECEPTOR HOMOLOG 1; RAD54 PROTEIN; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SUMOYLATION;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY, AMINO ACID; STEROIDOGENIC FACTOR 1; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 70350223560     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-12-1247     Document Type: Article

References (69)

1. Aalfs, J. D., and Kingston, R. E. (2000). What does 'chromatin remodeling' mean? Trends Biochem. Sci. 25, 548-555.
2. Alexeev, A., Mazin, A., and Kowalczykowski, S. C. (2003). Rad54 protein possesses chromatin-remodeling activity stimulated by the Rad51-ssDNA nucleoprotein filament. Nat. Struct. Biol. 10, 182-186.
3. Ascoli, M. (1981). Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 108, 88-95. (Pubitemid 11212802)
4. Auble, D. T., Hansen, K. E., Mueller, C. G., Lane, W. S., Thorner, J., and Hahn, S. (1994). Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev. 8, 1920-1934. (Pubitemid 24273892)
5. Becker, P. B., and Horz, W. (2002). ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71, 247-273.
6. Bugreev, D. V., Mazina, O. M., and Mazin, A. V. (2006). Rad54 protein promotes branch migration of Holliday junctions. Nature 442, 590-593.
7. Campbell, L. A., Faivre, E. J., Show, M. D., Ingraham, J. G., Flinders, J., Gross, J. D., and Ingraham, H. A. (2008). Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol. Cell. Biol. 28, 7476-7486.
8. Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., and Parker, M. G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
9. Chen, W. Y., Lee, W. C., Hsu, N. C., Huang, F., and Chung, B. C. (2004). SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1). J. Biol. Chem. 279, 38730-38735. (Pubitemid 39296031)
10. Christian, M., Tullet, J. M., and Parker, M. G. (2004). Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J. Biol. Chem. 279, 15645-15651.
11. Dammer, E. B., Leon, A., and Sewer, M. B. (2007). Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol. Endocrinol. 21, 415-438.
12. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
13. Dohmen, R. J. (2004). SUMO protein modification. Biochim. Biophys. Acta 1695, 113-131.
14. Domanskyi, A., Virtanen, K. T., Palvimo, J. J., and Janne, O. A. (2006). Biochemical characterization of androgen receptor-interacting protein 4. Biochem. J. 393, 789-795. (Pubitemid 43163819)
15. Epping, M. T., Wang, L., Edel, M. J., Carlee, L., Hernandez, M., and Bernards, R. (2005). The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122, 835-847. (Pubitemid 41345202)
16. Fernandes, I., et al. (2003). Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11, 139-150. (Pubitemid 36126597)
17. Flaus, A., Martin, D. M., Barton, G. J., and Owen-Hughes, T. (2006). Identification of multiple distinct Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res. 34, 2887-2905. (Pubitemid 44540417)
18. Geiss-Friedlander, R., and Melchior, F. (2007). Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956.
19. Gill, G. (2004). SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18, 2046-2059.
20. Gill, G. (2005). Something about SUMO inhibits transcription. Curr. Opin. Genet Dev. 15, 536-541.
21. Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., and Hay, R. T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054. (Pubitemid 36566325)
22. Gocke, C. B., Yu, H., and Kang, J. (2005). Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280, 5004-5012.
23. Hannich, J. T., Lewis, A., Kroetz, M. B., Li, S. J., Heide, H., Emili, A., and Hochstrasser, M. (2005). Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280, 4102-4110.
24. Hay, R. T. (2005). SUMO: a history of modification. Mol. Cell 18, 1-12.
25. Hecker, C. M., Rabiller, M., Haglund, K., Bayer, P., and Dikic, I. (2006). Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281, 16117-16127.
26. Ingraham, H. A., Lala, D. S., Ikeda, Y., Luo, X., Shen, W. H., Nachtigal, M. W., Abbud, R., Nilson, J. H., and Parker, K. L. (1994). The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8, 2302-2312. (Pubitemid 24314292)
27. Jaskelioff, M., Van Komen, S., Krebs, J. E., Sung, P., and Peterson, C. L. (2003). Rad54p is a chromatin remodeling enzyme required for heteroduplex DNA joint formation with chromatin. J. Biol. Chem. 278, 9212-9218.
28. Johnson, E. S. (2004). Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382.
29. Kagey, M. H., Melhuish, T. A., and Wotton, D. (2003). The polycomb protein Pc2 is a SUMO E3. Cell 113, 127-137.
30. Kerscher, O. (2007). SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 8, 550-555.
31. Komatsu, T., et al. (2004). Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 18, 2451-2462.
32. Laurent, B. C., Treich, I., and Carlson, M. (1993). The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7, 583-591. (Pubitemid 23125259)
33. Lee, M. B., Lebedeva, L. A., Suzawa, M., Wadekar, S. A., Desclozeaux, M., and Ingraham, H. A. (2005). The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol. Cell. Biol. 25, 1879-1890.
34. Lewis, A. E., Rusten, M., Hoivik, E. A., Vikse, E. L., Hansson, M. L., Wallberg, A. E., and Bakke, M. (2008). Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. Mol. Endocrinol. 22, 91-104.
35. Li, W., Hesabi, B., Babbo, A., Pacione, C., Liu, J., Chen, D. J., Nickoloff, J. A., and Shen, Z. (2000). Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein. Nucleic Acids Res. 28, 1145-1153. (Pubitemid 30107684)
36. Lin, D. Y., Fang, H. I., Ma, A. H., Huang, Y. S., Pu, Y. S., Jenster, G., Kung, H. J., and Shih, H. M. (2004). Negative modulation of androgen receptor transcriptional activity by Daxx. Mol. Cell. Biol. 24, 10529-10541.
37. Lin, D. Y., et al. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354.
38. Liu, H., Mulholland, N., Fu, H., and Zhao, K. (2006). Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Mol. Cell. Biol. 26, 2550-2559.
39. Liu, R., Liu, H., Chen, X., Kirby, M., Brown, P. O., and Zhao, K. (2001). Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106, 309-318. (Pubitemid 32772615)
40. Lund, J., Borud, B., Mellgren, G., Aesoy, R., Hoang, T., Jacob, A. L., and Bakke, M. (2002). Differential regulation of SF-1-cofactor interactions. Endocr. Res. 28, 505-513.
41. Luo, X., Ikeda, Y., and Parker, K. L. (1994). A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490. (Pubitemid 24153989)
42. Lusser, A., and Kadonaga, J. T. (2003). Chromatin remodeling by ATP-dependent molecular machines. Bioessays 25, 1192-1200. (Pubitemid 37499319)
43. Martin, S., Wilkinson, K. A., Nishimune, A., and Henley, J. M. (2007). Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8, 948-959.
44. Marx, J. (2005). Cell biology. SUMO wrestles its way to prominence in the cell. Science 307, 836-839.
45. Metivier, R., Penot, G., Hubner, M. R., Reid, G., Brand, H., Kos, M., and Gannon, F. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763. (Pubitemid 38030303)
46. Morohashi, K., et al. (1999). Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. Blood 93, 1586-1594. (Pubitemid 29102486)
47. Mukai, T., Kusaka, M., Kawabe, K., Goto, K., Nawata, H., Fujieda, K., and Morohashi, K. (2002). Sexually dimorphic expression of Dax-1 in the adrenal cortex. Genes Cells 7, 717-729. (Pubitemid 34814762)
48. Nuclear Receptors Nomenclature Committee. (1999). A unified nomenclature system for the nuclear receptor superfamily. Cell 97, 161-163.
49. Rosendorff, A., Sakakibara, S., Lu, S., Kieff, E., Xuan, Y., DiBacco, A., Shi, Y., Shi, Y., and Gill, G. (2006). NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. USA 103, 5308-5313.
50. Rouleau, N., Domans'kyi, A., Reeben, M., Moilanen, A. M., Havas, K., Kang, Z., Owen-Hughes, T., Palvimo, J. J., and Janne, O. A. (2002). Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription. Mol. Biol. Cell 13, 2106-2119.
51. Seeler, J. S., and Dejean, A. (2001). SUMO: of branched proteins and nuclear bodies. Oncogene 20, 7243-7249.
52. Seeler, J. S., and Dejean, A. (2003). Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4, 690-699.
53. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. (2000). Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
54. Shen, Z., Pardington-Purtymun, P. E., Comeaux, J. C., Moyzis, R. K., and Chen, D. J. (1996). UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics 36, 271-279. (Pubitemid 26307489)
55. Stielow, B., Sapetschnig, A., Kruger, I., Kunert, N., Brehm, A., Boutros, M., and Suske, G. (2008). Identification of SUMO-dependent chromatin-associated transcriptional repression components by a genome-wide RNAi screen. Mol. Cell 29, 742-754.
56. Sugawara, T., Saito, M., and Fujimoto, S. (2000). Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 141, 2895-2903. (Pubitemid 32250453)
57. Suzuki, T., Kasahara, M., Yoshioka, H., Morohashi, K., and Umesono, K. (2003). LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol. Cell. Biol. 23, 238-249.
58. Tang, J., Wu, S., Liu, H., Stratt, R., Barak, O. G., Shiekhattar, R., Picketts, D. J., and Yang, X. (2004). A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J. Biol. Chem. 279, 20369-20377.
59. Uchimura, Y., Ichimura, T., Uwada, J., Tachibana, T., Sugahara, S., Nakao, M., and Saitoh, H. (2006). Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J. Biol. Chem. 281, 23180-23190.
60. Uchimura, Y., Nakamura, M., Sugasawa, K., Nakao, M., and Saitoh, H. (2004). Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli. Anal. Biochem. 331, 204-206. (Pubitemid 38881579)
61. Val, P., Lefrancois-Martinez, A. M., Veyssiere, G., and Martinez, A. (2003). SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 1, 8.
62. Van Komen, S., Petukhova, G., Sigurdsson, S., Stratton, S., and Sung, P. (2000). Superhelicity-driven homologous DNA pairing by yeast recombination factors Rad51 and Rad54. Mol. Cell 6, 563-572.
63. Verger, A., Perdomo, J., and Crossley, M. (2003). Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4, 137-142.
64. Winnay, J. N., and Hammer, G. D. (2006). Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation. Mol. Endocrinol. 20, 147-166.
65. Xue, Y., Gibbons, R., Yan, Z., Yang, D., McDowell, T. L., Sechi, S., Qin, J., Zhou, S., Higgs, D., and Wang, W. (2003). The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA 100, 10635-10640.
66. Yang, S. H., and Sharrocks, A. D. (2004). SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13, 611-617. (Pubitemid 38299387)
67. Yang, W. H., Heaton, J. H., Brevig, H., Mukherjee, S., Iniguez-Lluhi, J. A., and Hammer, G. D. (2009). SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Mol. Cell. Biol. 29, 613-625.
68. Zhao, J. (2007). Sumoylation regulates diverse biological processes. Cell Mol. Life Sci. 64, 3017-3033.
69. Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M., and Yao, T. P. (2005). Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol. 25, 8456-8464.